Pliant Therapeutics's total assets for Q2 2025 were $299.82M, a decrease of -13.04% from the previous quarter. PLRX total liabilities were $79.74M for the fiscal quarter, a -8.98% a decrease from the previous quarter. See a summary of the company’s assets, liabilities, and equity.